Lista de obras -

Abstract 5578: IGF-1R nuclear staining in tumor cells identifies sarcoma patients with a prolonged progression free survival after IGF-1R monoclonal antibody therapy

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas

artículo científico publicado en 2013

ET-743: a novel agent with activity in soft tissue sarcomas

artículo científico publicado en 2005

ET-743: a novel agent with activity in soft-tissue sarcomas

artículo científico publicado en 2006

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution

artículo científico publicado en 2010

Emerging drugs for the treatment of soft tissue sarcomas

artículo científico publicado en 2007

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

artículo científico publicado en 2017

Imatinib and solid tumours

artículo científico publicado en 2008

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

scientific article published on May 2008

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

artículo científico publicado en 2011

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas

artículo científico publicado en 2012

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome

artículo científico publicado en 2015

Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib

artículo científico publicado en 2008

Targeted cancer therapies.

artículo científico publicado en 2005

Targeted therapy of sarcomas

artículo científico publicado en 2008

Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas.

artículo científico publicado en 2004

Therapeutic pipeline for soft-tissue sarcoma

artículo científico publicado en 2011

Lista de obras de

Abstract 5578: IGF-1R nuclear staining in tumor cells identifies sarcoma patients with a prolonged progression free survival after IGF-1R monoclonal antibody therapy

Autocrine role for Gas6 with Tyro3 and Axl in leiomyosarcomas

ET-743: a novel agent with activity in soft tissue sarcomas

ET-743: a novel agent with activity in soft-tissue sarcomas

Efficacy of trabectedin for advanced sarcomas in clinical trials versus compassionate use programs: analysis of 92 patients treated in a single institution

Emerging drugs for the treatment of soft tissue sarcomas

Expression and role of TYRO3 and AXL as potential therapeutical targets in leiomyosarcoma

Imatinib and solid tumours

Imatinib mesilate for the treatment of gastrointestinal stromal tumour

Incidence of sarcoma histotypes and molecular subtypes in a prospective epidemiological study with central pathology review and molecular testing

Insulin-like growth factor type 1 receptor (IGF-1R) exclusive nuclear staining: a predictive biomarker for IGF-1R monoclonal antibody (Ab) therapy in sarcomas

KIT exon 10 variant (c.1621 A > C) single nucleotide polymorphism as predictor of GIST patient outcome

Novel approaches to gastrointestinal stromal tumors resistant to imatinib and sunitinib

Targeted cancer therapies.

Targeted therapy of sarcomas

Targeting other abnormal signaling pathways in sarcoma: EGFR in synovial sarcomas, PPAR-gamma in liposarcomas.

Therapeutic pipeline for soft-tissue sarcoma